Century Therapeutics, Inc. (IPSC)
NASDAQ · Healthcare
Century Therapeutics, Inc. Shareholder Equity 2022–2025
Century Therapeutics, Inc. annual/quarterly shareholder equity history from 2022 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Century Therapeutics, Inc. shareholder equity for the quarter ending December 31, 2025 were 158.9M, a 1.50% decrease year-over-year.
- Century Therapeutics, Inc. shareholder equity for 2025 were 158.9M, a 1.50% decrease from 2024.
- Century Therapeutics, Inc. shareholder equity for 2024 were 161.4M, a 12.66% decrease from 2023.
- Century Therapeutics, Inc. shareholder equity for 2023 were 184.8M, a 38.97% decrease from 2022.
- Century Therapeutics, Inc. shareholder equity for 2022 were 302.7M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Century Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $159 |
| 2024 | $161 |
| 2023 | $185 |
| 2022 | $303 |
| Century Therapeutics, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $159 |
| 2024-12-31 | $161 |
| 2023-12-31 | $185 |
| 2022-12-31 | $303 |
Century Therapeutics, Inc. Shareholder Equity — FAQ
Century Therapeutics, Inc. (IPSC) shareholder equity over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IPSC's shareholder equity history?
The chart and table above show Century Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.